SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical and Applied Thrombosis/Hemostasis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lewandowski, K.
Right arrow Articles by Zawilska, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lewandowski, K.
Right arrow Articles by Zawilska, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Normal Sialophorine (CD43) Expression in a Thrombocytopenic and Immunodeficient Woman Carrier of Wiskott—Aldrich Syndrome

Krzysztof Lewandowski, M.D.

Department of Haematology, Karol Marcinkowski University of Medical Sciences

Maria Zozulinska, Ph.D.

Department of Haematology, Karol Marcinkowski University of Medical Sciences

Adam Szczepanik, Ph.D

Department of Intensive Therapy, Karol Marcinkowski University of Medical Sciences

Grzegorz Dworacki, M.D.

Department of Immunopathology, Karol Marcinkowski University of Medical Sciences

Hanna Tilgner, Ph.D

Department of Clinical Pathomorphology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland

Krystyna Zawilska, M.D.

Department of Haematology, Karol Marcinkowski University of Medical Sciences

We report on a 24-year-old thrombocytopenic woman with a history of recurrent infections, skin and mucosal bleeding, and a member of a family with the Wiskott—Aldrich syndrome. Hemorrhagic complications occurred at age 20, when mild peripheral thrombocyto penia (38-52 g/L) was confirmed. Four male family mem bers died of infectious complications at ages ranging from 6 months to 3 years. At the time of the study, she was free of infection. Physical examination exhibited ecchymoses of skin of the legs only, and her laboratory investigations demonstrated a lack of secondary waves of platelet ag gregation with adenosine diphosphate (ADP) and prolon gation of the lag phase after collagen stimulation. Inten sities of aggregation induced by ADP, collagen, and thrombin were decreased. Patient's plasma aggregating activity was diminished. Abnormal intraplatelet malo nylodialdehyde formation was also found. Assessment of the platelet volume distribution demonstrated the pres ence of normal-size population. Examination of isolated platelets by electron microscope showed a reduced num ber of dense bodies. The content of mepacrine-labeled platelet bodies in the fluorescent microscopy study was also diminished. Immunological investigations revealed a slight decrease in immunoglobulin G (IgG) serum concen tration and a low isohemagglutinin titer. Additionally, di minished percentages of T activated and total B cells were detected. Moreover, a slight increase of natural killer cells was revealed. Lymphocyte surface sialophorin (CD43) expression was normal. Polymorphonuclear cell (PMN) phagocytosis, chemotaxis, spontaneous migra tion, intravascular polymorphonuclear granulocyte aggre gate number, and Fc IgG receptor expression study all showed no abnormalities. However, a reduced bacteri cidal capacity of the PMN, reduced adhesion to albumin- covered plastic surfaces, and diminished resting super oxide/hydrogen peroxide production were found. Key Words: Wiskott-Aldrich syndrome carrier—Thrombo cytopenia—Immunodeficiency.

Clinical and Applied Thrombosis/Hemostasis, Vol. 2, No. 2, 137-141 (1996)
DOI: 10.1177/107602969600200209


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement